High sensitivity cardiac troponin T levels tied to swollen joints and disease activity in RA patients
Norway: According to new data, High-sensitivity cardiac troponin T ((hsTnT) levels in inflammatory arthritis (IA) patients were correlated positively with the markers of disease activity like swollen joints and levels of serum tumour necrosis factor.
IA patients suffer a substantial risk of developing coronary heart disease (CHD) independently of conventional risk factors. It is already known that hsTnT is used as a heart disease marker; it is a marker of myocyte necrosis and injury. Previous studies have shown its potential role in inflammation in other body parts, like the joints.
HsTnT is increased in IA patients. The mechanisms remain unclear, but accumulation suggests inflammation and rupture of atherosclerotic plaques.
Considering the background mentioned above, researchers hypothesized that “hsTnT levels correlate with systemic inflammatory and clinical markers for Inflammatory Arthritis disease activity and may be influenced by antirheumatic therapy.”
The researchers assessed 115 patients with active IA before and after using methotrexate (MTX) alone or tumour necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). The clinical and laboratory parameters were evaluated at baseline and after six weeks and six months of treatment.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.